Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Inhaled Technosphere Insulin vs Subcutaneous Insulin in Type 1 Diabetes
NCT00308308Phase 3Completed
- Sponsor
- MannKind
- Start
- Feb 2006
- Primary completion
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 3 trial of TI-Inhalation Powder B in type 1 diabetes mellitus (T1D), sponsored by MannKind. Started Feb 2006; status: completed.
02
Drugs
TI-Inhalation Powder B
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00308308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00308308.